Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates

Go back to Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates
(NASDAQ: VRDN) Delayed: 21.81 -0.19 (0.86%)
Previous Close $22.00    52 Week High
Open $22.28    52 Week Low
Day High $22.40    P/E N/A 
Day Low $21.63    EPS
Volume 722,137